Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-22894

Single-particle
3.6 Å
EMD-22894
3D View Gallery
Deposition: 25/10/2020
Map released: 11/11/2020
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-22894
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 7kj5 summary report (pdf.gz) Map and 7kj5 FULL report (pdf.gz)
EMICSS annotations (xml)

SARS-CoV-2 Spike Glycoprotein, prefusion with one RBD up conformation

EMD-22894

Single-particle
3.6 Å
EMD-22894
3D View Gallery
Deposition: 25/10/2020
Map released: 11/11/2020
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 Spike Glycoprotein, prefusion with one RBD-up conformation
Fitted models: 7kj5

Deposition Authors: Zhang J , Xiao TS
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent.
Xiao T , Lu J, Zhang J , Johnson RI , McKay LGA , Storm N , Lavine CL, Peng H, Cai Y , Rits-Volloch S, Lu S, Quinlan BD, Farzan M , Seaman MS, Griffiths A, Chen B
(2021) Nat Struct Mol Biol , 28 , 202 - 209
PUBMED: 33432247
DOI: doi:10.1038/s41594-020-00549-3
ISSN: 1545-9985